Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

About JACC CME
Hardware/Software Requirements
Contact Us
Policy on Privacy and Confidentiality
Copyright Information

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research
ACC 2009 Survey Results and Recommendations: Addressing the Cardiology Workforce Crisis
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:1820-1826
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, M.
Right arrow Articles by Kinoshita, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, M.
Right arrow Articles by Kinoshita, M.

CLINICAL STUDY: MYOCARDIAL INFARCTION

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

Masaru Hayashi, MDa, Takayoshi Tsutamoto, MDa, Atsuyuki Wada, MDa, Keiko Maeda, MDa, Naoko Mabuchi, MDa, Takashi Tsutsui, MDa, Hajime Horie, MDa, Masato Ohnishi, MDa and Masahiko Kinoshita, MDa

a First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Japan

Manuscript received November 1, 2000; revised manuscript received January 30, 2001, accepted February 15, 2001.

Reprint requests and correspondence: Dr. Takayoshi Tsutamoto, First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu 520-2192, Japan
tutamoto{at}belle.shiga-med.ac.jp

OBJECTIVES

The study evaluates the effect of atrial natriuretic peptide (ANP) compared with nitroglycerin (GTN) on left ventricular (LV) remodeling after first anterior acute myocardial infarction (AMI).

BACKGROUND

Compared with GTN, ANP suppresses the renin-angiotensin-aldosterone system and endothelin-1 (ET-1), which stimulate LV remodeling.

METHODS

Sixty patients with a first anterior AMI were randomly divided into the ANP (n = 30) or GTN (n = 30) groups after direct percutaneous transluminal coronary angioplasty. We evaluated LV ejection fraction (LVEF), end-diastolic volume index (LVEDVI) and end-systolic volume index (LVESVI) at the acute phase and after one month. We also measured neurohumoral factors during study drug infusion.

RESULTS

There was no difference in the baseline characteristics or LVEF (46.9 ± 1.0 vs. 46.8 ± 1.3%) between the two groups. Although there was no difference in hemodynamics during the infusion periods, the LVEF was significantly improved after one month compared with the baseline value in both groups, but it was improved more in the ANP group than in the GTN group (54.6 ± 1.1%, 50.8 ± 1.3%, p < 0.05). Left ventricular enlargement was prevented in the ANP group (LVEDVI, 85.8 ± 3.1 ml/m2 to 87.3 ± 2.7 ml/m2; p = ns, LVESVI, 45.6 ± 1.8 ml/m2 to 41.0 ± 2.1 ml/m2, p < 0.05) but not in the GTN group (LVEDVI, 86.2 ± 4.1 to 100.2 ± 3.7, p < 0.01; LVESVI, 46.3 ± 2.8 ml/m2 to 51.1 ± 3.0 ml/m2, p = ns). During the infusion, ANP suppressed plasma levels of aldosterone, angiotensin II and ET-1 compared with GTN.

CONCLUSIONS

These findings indicate that in patients with a first anterior AMI, an ANP infusion can prevent LV remodeling better than can GTN, and effectively suppresses aldosterone, angiotensin II and ET-1.

Abbreviations and Acronyms
  ALD = aldosterone
  AMI = acute myocardial infarction
  Ang II = angiotensin II
  ANP = atrial natriuretic peptide
  BNP = brain natriuretic peptide
  cGMP = cyclic guanosine monophosphate
  CK = creatine phosphokinase
  ET-1 = endothelin-1
  GTN = nitroglycerin
  LV = left ventricular
  LVEDVI = left ventricular end-diastolic volume index
  LVEF = left ventricular ejection fraction
  TIMI = Thrombolysis In Myocardial Infarction




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
A. Sezai, M. Hata, T. Niino, I. Yoshitake, S. Unosawa, S. Wakui, S. Osaka, T. Takayama, Y. Kasamaki, A. Hirayama, et al.
Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study.
J. Am. Coll. Cardiol., September 15, 2009; 54(12): 1058 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
H H Chen, F L Martin, R J Gibbons, J A Schirger, R S Wright, R M Schears, M M Redfield, R D Simari, A Lerman, A Cataliotti, et al.
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study
Heart, August 15, 2009; 95(16): 1315 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
A M. Richards
Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction
Heart, August 15, 2009; 95(16): 1299 - 1300.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. George, B. Morrow, K. Xu, G.-H. Yi, J. Holmes, E. X. Wu, Z. Li, A. A. Protter, M. C. Oz, and J. Wang
Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H708 - H717.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea
Myocardial no-reflow in humans.
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 281 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Inserte, J. A. Barrabes, V. Hernando, and D. Garcia-Dorado
Orphan targets for reperfusion injury
Cardiovasc Res, July 15, 2009; 83(2): 169 - 178.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
O. Tsukamoto, M. Fujita, M. Kato, S. Yamazaki, Y. Asano, A. Ogai, H. Okazaki, M. Asai, Y. Nagamachi, N. Maeda, et al.
Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2070 - 2077.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. K. Houng, R. A. McNamee, A. Kerner, P. Sharma, A. Mohamad, J. Tronolone, and G. L. Reed
Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H655 - H661.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Ishii, T. Amano, T. Matsubara, and T. Murohara
Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction
Circulation, December 16, 2008; 118(25): 2710 - 2718.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. S. Francis
From B-type natriuretic Peptide to green mambas the process of discovery.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 69 - 70.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
Eur. Heart J., June 2, 2008; 29(12): 1485 - 1494.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
G. W Yip
B-type natriuretic peptide: a treatment, not a diagnostic marker
Heart, May 1, 2008; 94(5): 542 - 544.
[Full Text] [PDF]

Home page
 HeartHome page
R J Hillock, C M Frampton, T G Yandle, R W Troughton, J G Lainchbury, and A M Richards
B-type natriuretic peptide infusions in acute myocardial infarction
Heart, May 1, 2008; 94(5): 617 - 622.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
T. Tanaka, T. Tsutamoto, H. Sakai, K. Nishiyama, M. Fujii, T. Yamamoto, and M. Horie
Effect of atrial natriuretic peptide on adiponectin in patients with heart failure
Eur J Heart Fail, April 1, 2008; 10(4): 360 - 366.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. M. Richards
Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use
Hypertension, July 1, 2007; 50(1): 25 - 30.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Kasama, T. Toyama, T. Hatori, H. Sumino, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 667 - 674.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Otake, J. Shite, O. L. Paredes, T. Shinke, R. Yoshikawa, Y. Tanino, S. Watanabe, T. Ozawa, D. Matsumoto, D. Ogasawara, et al.
Catheter-Based Transcoronary Myocardial Hypothermia Attenuates Arrhythmia and Myocardial Necrosis in Pigs With Acute Myocardial Infarction
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 250 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Nishikimi, N. Maeda, and H. Matsuoka
The role of natriuretic peptides in cardioprotection
Cardiovasc Res, February 1, 2006; 69(2): 318 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Clerico, F. A. Recchia, C. Passino, and M. Emdin
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H17 - H29.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Nakanishi, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, Y. Nakagawa, K. Tanimoto, S. Yasuno, et al.
Role of Natriuretic Peptide Receptor Guanylyl Cyclase-A in Myocardial Infarction Evaluated Using Genetically Engineered Mice
Hypertension, August 1, 2005; 46(2): 441 - 447.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Tsuneyoshi, T. Nishina, T. Nomoto, H. Kanemitsu, R. Kawakami, O. Unimonh, K. Nishimura, and M. Komeda
Atrial Natriuretic Peptide Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair
Circulation, September 14, 2004; 110(11_suppl_1): II-174 - II-179.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
M.-H. Song, Y. Kobayashi, and H. Michi
Clinical Implication of Atrial and Brain Natriuretic Peptide in Coronary Artery Bypass Grafting
Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 41 - 46.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. D. Michaels, A. Klein, J. A. Madden, and K. Chatterjee
Effects of Intravenous Nesiritide on Human Coronary Vasomotor Regulation and Myocardial Oxygen Uptake
Circulation, June 3, 2003; 107(21): 2697 - 2701.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Hayashi, T. Tsutamoto, A. Wada, T. Tsutsui, C. Ishii, K. Ohno, M. Fujii, A. Taniguchi, T. Hamatani, Y. Nozato, et al.
Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction
Circulation, May 27, 2003; 107(20): 2559 - 2565.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
T. Tsutamoto, A. Wada, M. Hayashi, T. Tsutsui, K. Maeda, M. Ohnishi, M. Fujii, T. Matsumoto, T. Yamamoto, T. Takayama, et al.
Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction
Eur. Heart J., February 2, 2003; 24(4): 346 - 355.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
N. Lapointe, C. Blais Jr, A. Adam, T. Parker, M. G. Sirois, H. Gosselin, R. Clement, and J. L. Rouleau
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat
J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1692 - 1698.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Wu, W. Yan, J. Pan, J. Morser, and Q. Wu
Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes
J. Biol. Chem., May 3, 2002; 277(19): 16900 - 16905.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Hayashi, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, T. Tsutsui, T. Matsui, M. Fujii, T. Matsumoto, T. Yamamoto, et al.
Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1375 - 1382.
[Abstract] [Full Text] [PDF]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement